Results 151 to 160 of about 8,376 (205)

N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTP. [PDF]

open access: yesBlood Adv
Postmus T   +9 more
europepmc   +1 more source

An observational, non-interventional, multicenter, multinational registry of patients with atypical hemolytic uremic syndrome: methodology [PDF]

open access: yes, 2013
Ardissino, Gianluigi   +10 more
core  

Challenges in managing iTTP: insights into ADAMTS13 inhibitor boosting during caplacizumab therapy. [PDF]

open access: yesAnn Hematol
Tanaka H   +9 more
europepmc   +1 more source

Imbalanced VWF-ADAMTS13 axis contributes to the detrimental impact of a preceding respiratory tract infection on stroke. [PDF]

open access: yesBlood Adv
Patel RB   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy